The Last Beat: Contemporary Ethical Controversies Surrounding Determination of Cardiopulmonary Death.

CPR autoresuscitation circulatory death determination of death

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
02 2022
Historique:
received: 21 06 2021
revised: 09 08 2021
accepted: 16 08 2021
entrez: 8 2 2022
pubmed: 9 2 2022
medline: 11 3 2022
Statut: ppublish

Résumé

Part one of this series tracked the evolution of the death examination, noting its stability over the last century despite changing diagnostic and therapeutic technologies and social contexts. In part two, we discuss the practical and ethical debates surrounding the exact timing of death. Although the irreversible cessation of cardiopulmonary systems remains the most common criteria used for the determination of death, identification of the moment of irreversibility is imprecise. In most cases, this imprecision is not problematic, but, when the cessation of circulation is used to identify the time of organ procurement for transplantation, it becomes critical. The phenomenon of autoresuscitation highlights these issues because patients who meet all the criteria for circulatory death (sometimes for periods of observation well beyond the norm) apparently return to life. Were these patients resurrected (like Lazarus) or did we simply not wait long enough?

Identifiants

pubmed: 35131058
pii: S0012-3692(21)03836-8
doi: 10.1016/j.chest.2021.08.064
pii:
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-523

Commentaires et corrections

Type : CommentOn

Informations de copyright

Published by Elsevier Inc.

Auteurs

Anthony C Breu (AC)

Medical Service, Veteran Affairs Boston Healthcare System, West Roxbury, MA; Center for Bioethics, Harvard Medical School, Boston, MA. Electronic address: anthony.breu@va.gov.

Adam Rodman (A)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH